All In Biotech

Drug Trial Radar · NCT06531811

A Study to Investigate the Relative Bioavailability of AZD8630 Following a Device and Formulation Transition in Healthy Participants.

A Randomized, Open-label, Single-dose, 2-Treatment, 2-Period, Crossover Study to Assess the Relative Bioavailability of AZD8630 Following a Device and Formulation Transition in Healthy Participants.

Last checked: Nov 19, 2026Latest source record: Oct 17, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

32

Actual

Start

Aug 6, 2024

Primary completion

Oct 3, 2024

Study completion Oct 3, 2024

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
Aug 1, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Other
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the potential difference between pharmacokinetics (PK), safety, tolerability and device performance between the AZD8630 test formulation and the AZD8630 reference formulation.

Conditions

  • Healthy Participants

Interventions

  • AZD8630 (test formulation) via test inhalerDrug

    Participants will receive AZD8630 via test inhaler.

  • AZD8630 (reference formulation) via Monodose inhalerDrug

    Participants will receive AZD8630 via Monodose inhaler.

  • Test inhalerDevice

    Participants will receive AZD8630 via test inhaler.

  • Monodose inhalerDevice

    Participants will receive AZD8630 via Monodose inhaler.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Area under the serum concentration-time curve from time zero to the last quantifiable concentration test/MonodoseTime frame: From Baseline Day 1 to Day 11

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Research Site

    Baltimore, Maryland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.